With Nasal Ease U.S. Launch, Hi-Tech Bids For Allergy Relief Market Share

Hi-Tech Pharmacal plans to launch its homeopathic allergy reliever Nasal Ease in the U.S. in a bid to capture some of the market share Matrixx Initiatives lost when it withdrew its intranasal Zicam products.